You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

15 Results
Guidelines and Advice
Status: Current
ID: 24-2
Version: 2
Jan 2019
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Guidelines and Advice
Status: Archived
ID: 2-20-2
Sep 2005
Guidelines and Advice
Statistical Reports
Statistical Reports
Drug
Other Name(s): Busulfex® , Myleran®
Jun 2019
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Intent: Curative, Adjuvant
Jan 2019

Pages